Short answer
ResMed (RMD) filed an 8-K current report with the SEC on September 1, 2026 reporting Item 8.01 (Other Events). $450M accelerated share repurchase announced, signaling capital return following MatrixCare business sale.
ResMed 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $450M accelerated share repurchase announced, signaling capital return following MatrixCare business sale
- $450M payment to Citibank scheduled September 3, 2026, funded by MatrixCare proceeds and cash on hand
- Initial share delivery equals 80% of $450M divided by September 2 closing price
- Final repurchased shares depend on average daily VWAP, discount, and contractual adjustments
- Final settlement scheduled December 2026, with potential company share delivery or cash payment at Citibank’s election
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ResMed 8-K filings
Get the next RMD 8-K as it lands
Follow RMD for push alerts, or ask the research agent what this filing means.